Ampio Pharmaceuticals Issues Letter to Stockholders – April 18, 2023

By /

Ampio Pharmaceuticals, Inc. released the following letter to stockholders from its Chairman, Kevin Buchi and Chief Executive Officer, Mike Martino.

Scroll to Top